Journal of the Japan Diabetes Society
Online ISSN : 1881-588X
Print ISSN : 0021-437X
ISSN-L : 0021-437X
Search
Advanced search
OR
Browse
Search
Volume 53, Issue 6
Displaying 1-9 of 9 articles from this issue
Show all abstracts
    • |<
    • <
    • 1
    • >
    • >|
Original Articles
  • Easy Estimation of Carbohydrate Count in Diabetic Diet Therapy Based on Japanese Food Substitution List
    Akio Kuroda, Naoko Nagai, Yuko Konishi, Mikiko Yamazaki, Keiko Shiraha ...
    2010 Volume 53 Issue 6 Pages 391-395
    Published: 2010
    Released on J-STAGE: August 18, 2010
    DOIhttps://doi.org/10.11213/tonyobyo.53.391
    JOURNAL FREE ACCESS
    Show abstractHide abstract
    Diets based on a food substitution list (Shokuhin Kokanhyo) are recommended to most subjects with diabetes in Japan, and the list has proved to be a good tool for nutrition teaching and body weight management. Carbohydrate counting used elsewhere, however, to control postprandial blood glucose has yet to be widely disseminated. We propose calculating carbohydrate content based on the food substitution list, using 40% rice, 50% bread, and 20% boiled noodles as dietary staples with sugar content and 20-gram side dish sugar content. The difference between the precise count based on the food substitution list and our estimation was within 10 g in over 90% of the diabetic diet of 1,200-1,760 kcal/day. This easy way of estimating carbohydrate content could prove helpful in achieving good glycemic control in Japanese subjects with diabetes.
    View full abstract
    Download PDF (524K)
  • Evidence-based Practice Guideline for Diabetes Treatment in Japan Reduces Cardiovascular Events
    Kazunari Matsumoto, Keiichiro Fujishima, Akie Moriuchi, Hiroe Saishoji
    2010 Volume 53 Issue 6 Pages 396-401
    Published: 2010
    Released on J-STAGE: August 18, 2010
    DOIhttps://doi.org/10.11213/tonyobyo.53.396
    JOURNAL FREE ACCESS
    Show abstractHide abstract
    The evidence-based practice guideline for diabetes treatment in Japan recommends HbA1C of <6.5%, blood pressure of <130/80 mmHg, and LDL-cholesterol of <120 mg/dl. To determine the impact of guideline adherence on cardiovascular event incidence, we evaluated 6-year follow-up data on 368 subjects with type 2 diabetes but no cardiovascular disease history. The endpoint was defined as acute myocardial infarction, angina pectoris, stroke, or sudden death. The 51 reaching an endpoint during follow-up were significantly older and had higher systolic blood pressure, HbA1C, plasma glucose, and LDL-cholesterol, and lower HDL-cholesterol than event-free subjects. Those achieving the guideline target of HbA1C <6.5% were 27.5% for events vs. 45.4% for event-free (p<0.05) . Similarly, those achiering the targeted blood pressure <130/80 mmHg were 15.7% vs. 42.0% (p<0.01) and of LDL-cholesterol <120 mg/dl were 68.6% vs. 70.3% (not significant) . In achievement by category number 0 or 1, 2, or 3-Kaplan-Meier survival analysis indicated a difference in cardiovascular event rate (p<0.01) . Event rate reduction was 64.4% for subjects achieving 2 categories and 79.9% for 3 vs. 0 or 1 category-similar to Cox's proportional hazard model of hazard ratio reduction, i.e., 68.7 for 2 categories and 82.6% for 3. Guideline adherence is thus prognostically beneficial in preventing cardiovascular events in Japanese subjects with diabetes, whose cardiovascular event incidence was clearly reduced when at least two guideline categories were achieved.
    View full abstract
    Download PDF (373K)
Case Reports
Report of the Committee
    • |<
    • <
    • 1
    • >
    • >|
feedback
 Top